News for Capricor Therapeutics, Inc. (4LN2.F)

Published at

Feb 1, 2021 3:15 PM

by benzinga.com

positive

positive

Capricor Therapeutics Announces Development of Serology Test to Confirm Activity of SARS-CoV-2 Vaccines

-Technology Licensed from Johns Hopkins University- -Patient Data Demonstrates Validity of Novel Imaging-Based Approach Furthering Capricor's Platform ...

CAPR 4LN2.F 4LN2.BE

Read more →
Published at

Jan 27, 2021 8:56 AM

by rttnews.com

mixed

mixed

AGIO's ACTIVATE-T Hits Goals, EDSA Catches Eye, JNJ Provides Rosy Outlook, VXRT On Watch

Today's Daily Dose brings you news about the progress of Vaxart's oral tablet COVID-19 vaccine candidate; Vir Biotech's phase I trial of VIR-3434 in chronic hepatitis B virus; Sorrento's COVID-19 program; Agios Pharma's phase III trial of Mitapivat and Johnson & Johnson's rosy outlook for 2021.

VXRT VIR RGO.SG RGO.MU RGO.F RGO.BE REGN.MX REGN AGIO NB11.SG NB11.MU NB11.F NB11.BE KRMD CVLB CAPR BTH1.MU BTH1.F BTH1.BE BP2M.F BP2M.BE BIOL AIKI 4LN2.F 4LN2.BE SRNE EDSA 8STN.MU 8STN.F 8STN.BE

Read more →